Skip to content

Clinical trials

Observational Non-alcoholic Fatty Liver Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Observational Country / region: China Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20111
20121
20141
20152
20164
20174
20184
20192
20204
20228
20235
20246
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status20
Recruiting15
Completed11
Active, not recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Friendship Hospital5
Ningbo No. 1 Hospital4
Beijing Municipal Administration of Hospitals2
Beijing Tsinghua Chang Gung Hospital2
Humanity and Health Research Centre2
Nanfang Hospital, Southern Medical University2
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine2
Yan Bi2
AstraZeneca1
Chinese PLA General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease51
Liver Cirrhosis8
Fatty Liver6
Fibrosis6
Hepatitis B, Chronic5
Diabetes Mellitus, Type 24
Carcinoma, Hepatocellular3
Obesity3
Acquired Immunodeficiency Syndrome2
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.